Clinical Trial Update: Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

View source ↗

Summary

The trial update indicates that islet transplantation using the UIC protocol by CellTrans has received marketing approval for Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Islet transplantation using the UIC Protocol

Snippet

Sponsor: CellTrans Inc. | Conditions: Type 1 Diabetes Mellitus | Status: APPROVED_FOR_MARKETING